jain.com

Q3 2026 Adjusted EBITDA

Company: Core Scientific

Subject kind
financing
Statement date
2026-11-05
Promised amount
134000000.0 USD
Current status
stated

The claim, verbatim

Adjusted EBITDA more than tripled to $134 million from $41 million in Q2, with margin expanding to 57% from 25%.

Source (primary)

[Core Scientific Q3 2026 Earnings Call] Colocation Revenue Jumps 60% to $215M, Adjusted EBITDA Triples to $134M as CoreWeave Capacity Hits 485 MW - BigGo Finance (-, news_article)
View cached copy (2026-11-06)Live source ↗Archive.org ↗

Quote: “Adjusted EBITDA more than tripled to $134 million from $41 million in Q2, with margin expanding to 57% from 25%.”

How we checked this

This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.

Additional evidence

confirms [Core Scientific Q3 2026 Earnings Call] Colocation Revenue Jumps 60% to $215M, Adjusted EBITDA Triples to $134M as CoreWeave Capacity Hits 485 MW - BigGo Finance

Quote: “Adjusted EBITDA more than tripled to $134 million from $41 million in Q2, with margin expanding to 57% from 25%.”

View cached copy (2026-11-06)Live source ↗Archive.org ↗